GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Unichem Laboratories Ltd (NSE:UNICHEMLAB) » Definitions » Purchase Of Business

Unichem Laboratories (NSE:UNICHEMLAB) Purchase Of Business : ₹0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2001. Start your Free Trial

What is Unichem Laboratories Purchase Of Business?

Unichem Laboratories's purchase of business for the three months ended in Mar. 2025 was ₹0 Mil. It means Unichem Laboratories spent ₹0 Mil on purchasing business. Unichem Laboratories's purchase of business for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0 Mil.

Compared with last quarter (₹0 Mil in Dec. 2024 ), Unichem Laboratories spent the same money on purchasing business in Mar. 2025 (₹0 Mil).

Unichem Laboratories Purchase Of Business Historical Data

The historical data trend for Unichem Laboratories's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Unichem Laboratories Purchase Of Business Chart

Unichem Laboratories Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Purchase Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -844.50

Unichem Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Purchase Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Unichem Laboratories Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Unichem Laboratories Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Unichem Laboratories's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Unichem Laboratories Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Unichem Laboratories Ltd (NSE:UNICHEMLAB) » Definitions » Purchase Of Business
Comparable Companies
BOM:530239 BOM:512529 BOM:524348 BOM:524735 NSE:INNOVACAP BOM:524372 BOM:509079 BOM:532872 BOM:500288 NSE:RPGLIFE ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
506690:India
Address
Off. S. V. Road, Unichem Bhavan, Prabhat Estate, Jogeshwari (West), Mumbai, MH, IND, 400 102
Website
https://www.unichemlabs.com
Unichem Laboratories Ltd is an India based pharmaceutical company. It manufactures a range of Active Pharmaceutical Ingredients (APIs). The company's products are offered in the areas of gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. Some of its products include Apixaban, Brimonidine Tartrate, Finofibrate, Glipizide, Piroxicam and others. The company has a global market presence with sales in India and outside India, and the majority of the revenue derived from India. Its product categories comprises Formulations and Bulk Drugs and Chemicals.

Unichem Laboratories Headlines

No Headlines